Admittedly, four data points aren't yet much of a trend, but it's worth pointing out we are seeing the beginnings of a resurgence in the venture-backed IPO market in 2010.
So far this year we have seen four non-biotech venture-backed deals, and they have all performed impressively, as the following table, click to enlarge, shows.
